By indication / Parkinsonian syndromes and movement disorders
Parkinsonian syndromes and movement disorders
17 imaging agents and 0 therapeutic agents reported for this indication. Stage reflects how far each has been taken, not what is available in any given country.
Imaging
| Agent | Isotope | Stage | Runs |
|---|---|---|---|
| [18F]FDOPA | F-18 | Approved | 26 |
| [18F]FE-PE2I | F-18 | — | 5 |
| [18F]MC225 | F-18 | — | 2 |
| [18F]FDDNP | F-18 | — | 1 |
| [18F]FMN3PA | F-18 | Preclinical | 1 |
| [18F]FMN3PU | F-18 | Preclinical | 1 |
| [18F]FP-CIT | F-18 | — | 1 |
| [18F]PBR06 | F-18 | — | 1 |
| [123I]MIBG paired with [131I]MIBG | I-123 | — | 1 |
| [11C]ER176 | C-11 | — | |
| [18F]pi2620 | F-18 | — | |
| [18F]ro948 | F-18 | — | |
| [18F]SMBT-1 | F-18 | — | |
| [123I]beta-CIT | I-123 | — | |
| [123I]FP-CIT | I-123 | Approved | |
| [123I]iodoamphetamine | I-123 | — | |
| [123I]R91150 | I-123 | — |
Therapy
Nothing indexed under this heading yet.
Other entries
| Agent | Isotope | Stage | Runs |
|---|---|---|---|
| [18F]FP-(+)-DTBZ | F-18 | — | 5 |
| [11C]-(+)-alpha-DTBZ | C-11 | — | 2 |
| [123I]I-IMP | I-123 | — |
Have a question?Reagents, modules, introductions to manufacturers or to specialists in your region - tell us what you need.
Get in touch